Extracorporeal membrane oxygenation: a ten-year experience - 05/09/11
Abstract |
Background: Extracorporeal membrane oxygenation (ECMO) is a supportive therapy used for severe acute respiratory distress syndrome (ARDS). We present outcome, clinical parameters, and complications in a cohort of 245 ARDS patients of whom 62 were treated with ECMO.
Methods: Data of all ARDS patients were prospectively collected between 1991 and 1999. Outcome and clinical parameters of patients treated with and without ECMO were evaluated.
Results: One hundred thirty-eight patients were referred from other hospitals, 107 were primarily located in our hospital. About one fourth of these patients were treated with ECMO. The survival rate was 55% in ECMO patients and 61% in non-ECMO patients.
Conclusions: ECMO is a therapeutic option for patients with severe ARDS, likely to increase survival. However, a randomized controlled study proving its benefit is still awaited. Until the development of a causal or otherwise superior therapy ECMO should be used in selected patients.
Le texte complet de cet article est disponible en PDF.Plan
Vol 180 - N° 2
P. 144-154 - août 2000 Retour au numéro
Article précédent
- A comparison of the prognostic significance of tumor diameter, length, width, thickness, area, volume, and clinicopathological features of oral tongue carcinoma
- Anthony Po Wing Yuen, King Yin Lam, William I Wei, Kin Yip Lam, Chiu Ming Ho, Tam Lin Chow, Wah Fun Yuen
- Paraganglioma of the carotid bifurcation
- Thomas J Kroencke, Ralph I Rueckert
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?